Merck KGaA wants to ditch FoB partnership with RDY: http://www.fiercepharma.com/pharma/merck-kgaa-advanced-talks-to-sell-off-biosims-unit-and-others-could-follow The collaboration announced five years ago (#msg-76359649) has yet to produce any regulatory approvals.